Search PDMR transactions

Notifier
Name of person with notification obligation
Carl-Fredrik Lindner
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Carl-Fredrik Lindner
Position
Chairman of the Board of Directors
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Annexin Pharmaceuticals AB (publ)
Issuer’s LEI code
5493000JP703HGPJEX27
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Annexin Pharmaceuticals AB SE0009664154 Acquisition 29,998 Quantity 1.78 SEK 23/12/2020 FIRST NORTH SWEDEN - SME GROWTH MARKET
Share Annexin Pharmaceuticals AB SE0009664154 Acquisition 3,000 Quantity 1.78 SEK 23/12/2020 FIRST NORTH SWEDEN - SME GROWTH MARKET
Share Annexin Pharmaceuticals AB SE0009664154 Acquisition 40,688 Quantity 1.80 SEK 23/12/2020 FIRST NORTH SWEDEN - SME GROWTH MARKET
Share Annexin Pharmaceuticals AB SE0009664154 Acquisition 2,145 Quantity 1.795 SEK 23/12/2020 FIRST NORTH SWEDEN - SME GROWTH MARKET
Share Annexin Pharmaceuticals AB SE0009664154 Acquisition 2,169 Quantity 1.775 SEK 23/12/2020 FIRST NORTH SWEDEN - SME GROWTH MARKET
Share Annexin Pharmaceuticals AB SE0009664154 Acquisition 2,000 Quantity 1.77 SEK 23/12/2020 FIRST NORTH SWEDEN - SME GROWTH MARKET
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Annexin Pharmaceuticals AB SE0009664154 Acquisition 23/12/2020 FIRST NORTH SWEDEN - SME GROWTH MARKET 80,000 (Quantity) 1.79018863 SEK
Total: 80,000
<< Back